Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Total Debt (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Total Debt for 12 consecutive years, with $45.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Debt rose 3474.31% year-over-year to $45.1 million, compared with a TTM value of $45.1 million through Sep 2025, up 3474.31%, and an annual FY2024 reading of $1.2 million, down 51.8% over the prior year.
  • Total Debt was $45.1 million for Q3 2025 at Sanara MedTech, up from $1.1 million in the prior quarter.
  • Across five years, Total Debt topped out at $45.1 million in Q3 2025 and bottomed at $1.1 million in Q2 2025.
  • Average Total Debt over 3 years is $8.0 million, with a median of $2.2 million recorded in 2023.
  • Peak annual rise in Total Debt hit 3474.31% in 2025, while the deepest fall reached 92.2% in 2025.
  • Year by year, Total Debt stood at $2.5 million in 2023, then tumbled by 51.8% to $1.2 million in 2024, then skyrocketed by 3609.21% to $45.1 million in 2025.
  • Business Quant data shows Total Debt for SMTI at $45.1 million in Q3 2025, $1.1 million in Q2 2025, and $1.2 million in Q1 2025.